Boundless Bio
Boundless Bio (Nasdaq: BOLD) is a San Diego, California based clinical-stage, next-generation precision oncology company founded in 2018 to target extrachromosomal DNA (ecDNA) — circular, centromere-free DNA that carries high copy-number oncogene amplifications and is observed in roughly 17% of cancer patients, driving tumor heterogeneity and resistance to targeted therapy. Its proprietary Spyglass discovery platform, built on a suite of ecDNA+/- tumor models plus molecular analytics and imaging, identifies targets essential to ecDNA function, which the company drugs with small-molecule ecDNA-directed therapies (ecDTx). The clinical pipeline is led by BBI-940, a kinesin inhibitor targeting ecDNA segregation, in the Phase 1 KOMODO-1 trial in ER+/HER2- and TNBC-LAR breast cancer opened in February 2026, with earlier CHK1 (replication stress) and RNR (DNA assembly and repair) programs behind it; ECHO, its ecDNA diagnostic algorithm, reads ecDNA off routine clinical next-generation sequencing and is described by the company as the first ecDNA diagnostic used in clinical trials. Boundless Bio raised a $100M Series C co-led by Leaps by Bayer and RA Capital and listed on Nasdaq in 2024. It publishes no developer program, no product API, no SDKs and no API documentation of any kind; the only machine-readable surface on boundlessbio.com is the WordPress REST API (wp/v2), anonymously readable, which serves the corporate pages, the Leadership directory and the media library as JSON.
Boundless Bio publishes 1 API on the APIs.io network. Tagged areas include Company, Biotechnology, Oncology, Precision Medicine, and Drug Discovery.
Boundless Bio’s developer surface includes support, authentication, and 24 more developer resources.
Kin Score
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
Boundless Bio Website (WordPress REST)
The public WordPress REST API (wp-json) of the Boundless Bio website at boundlessbio.com: the route index of the site's content management system, catalogued as one site surface...
Open Collections 1
Open, tool-agnostic API collections (OpenAPI-derived and Bruno).
API Collection
OPEN COLLECTIONSecurity Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Agentic Access 1
Recommended x-agentic-access execution contracts for AI agents.
Resources
Agent Surfaces 4
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 5
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.